Downstream Bioprocessing 2021

Titration for research grade rAAV: understanding challenges and minimum requirements

Cell & Gene Therapy Insights 2021; 7(11), 1535–1537


Published: 6 December 2021
Javier F Alcudia

Javier F Alcudia

Director, Stanford Gene Vector and Virus Core

“...when designing the vector, it is not always clear to the user what is needed from a manufacturing standpoint to make a product that will be suitable for patient use.”